Your browser doesn't support javascript.
loading
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.
Lewis, E J; Hunsicker, L G; Clarke, W R; Berl, T; Pohl, M A; Lewis, J B; Ritz, E; Atkins, R C; Rohde, R; Raz, I.
Affiliation
  • Lewis EJ; Department of Medicine, Rush-Presbyterian-St Luke's Medical Center, Chicago, IL 60612, USA.
N Engl J Med ; 345(12): 851-60, 2001 Sep 20.
Article in En | MEDLINE | ID: mdl-11565517
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tetrazoles / Biphenyl Compounds / Diabetes Mellitus, Type 2 / Diabetic Nephropathies / Angiotensin Receptor Antagonists / Antihypertensive Agents Type of study: Clinical_trials / Etiology_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: N Engl J Med Year: 2001 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tetrazoles / Biphenyl Compounds / Diabetes Mellitus, Type 2 / Diabetic Nephropathies / Angiotensin Receptor Antagonists / Antihypertensive Agents Type of study: Clinical_trials / Etiology_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: N Engl J Med Year: 2001 Document type: Article Affiliation country: Country of publication: